C
Chen Suo
Researcher at Fudan University
Publications - 43
Citations - 2113
Chen Suo is an academic researcher from Fudan University. The author has contributed to research in topics: Population & Odds ratio. The author has an hindex of 14, co-authored 43 publications receiving 940 citations. Previous affiliations of Chen Suo include Chinese Ministry of Education & Karolinska Institutet.
Papers
More filters
Journal ArticleDOI
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies.
Yi-Zhou Jiang,Ding Ma,Chen Suo,Shi Jinxiu,Mengzhu Xue,Xin Hu,Yi Xiao,Ke Da Yu,Yi Rong Liu,Ying Yu,Yuanting Zheng,Xiangnan Li,Chen-Hui Zhang,Peng-Chen Hu,Jing Zhang,Qi Hua,Jiyang Zhang,Wanwan Hou,Luyao Ren,Ding Bao,B. Li,Jingcheng Yang,Ling Yao,Wen Jia Zuo,Shen Zhao,Yue Gong,Yi Xing Ren,Ya Xin Zhao,Yun Song Yang,Niu Zhenmin,Zhi Gang Cao,Daniel G. Stover,Claire F. Verschraegen,Virginia G. Kaklamani,Anneleen Daemen,John R. Benson,Kazuaki Takabe,Fan Bai,Da Qiang Li,Peng Wang,Leming Shi,Wei Huang,Zhi Ming Shao +42 more
TL;DR: The LAR subtype showed more ERBB2 somatic mutations, infrequent mutational signature 3 and frequent CDKN2A loss than the other subtypes, and was classified as a mesenchymal-like subtype.
Journal ArticleDOI
The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention
Zhenqiu Liu,Yanfeng Jiang,Huangbo Yuan,Huangbo Yuan,Qiwen Fang,Qiwen Fang,Ning Cai,Chen Suo,Li Jin,Tiejun Zhang,Tiejun Zhang,Xingdong Chen +11 more
TL;DR: Liver cancer remains a major public health concern globally, Though control of hepatitis B and C virus infections has contributed to the decreasing incidence in some regions, an unfavorable trend in countries with a high socio-demographic index is observed.
Journal ArticleDOI
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test.
Xingdong Chen,Jeffrey A. Gole,Athurva Gore,He Qiye,Ming Lu,Ming Lu,Jun Min,Ziyu Yuan,Xiaorong Yang,Xiaorong Yang,Yanfeng Jiang,Tiejun Zhang,Chen Suo,Xiaojie Li,Lei Cheng,Zhenhua Zhang,Hongyu Niu,Zhe Li,Zhen Xie,Han Shi,Xiang Zhang,Min Fan,Xiaofeng Wang,Yajun Yang,Justin Dang,Catie McConnell,Juan Zhang,Jiucun Wang,Shun-Zhang Yu,Weimin Ye,Weimin Ye,Yuan Gao,Kun Zhang,Rui Liu,Li Jin +34 more
TL;DR: It is demonstrated that cancer can be non-invasively detected up to four years before current standard of care and patients whose disease is diagnosed in its early stages have better outcomes.
Journal ArticleDOI
Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer
Yi Xiao,Ding Ma,Shen Zhao,Chen Suo,Shi Jinxiu,Mengzhu Xue,Miao Ruan,Hai Wang,Jingjing Zhao,Qin Li,Peng Wang,Leming Shi,Wen-Tao Yang,Wei Huang,Xin Hu,Ke-Da Yu,Shenglin Huang,François Bertucci,Yi-Zhou Jiang,Zhi-Ming Shao +19 more
TL;DR: This study represents a step toward personalized immunotherapy for patients with TNBC and suggests that immune checkpoint inhibitors might be effective for “immune-inflamed” cluster, and the transformation of “cold tumors” into “hot tumors’ should be considered for ”immune-desert” and “innate immune-inactivated” clusters.
Journal ArticleDOI
Early prediction of mortality risk among patients with severe COVID-19, using machine learning.
Chuanyu Hu,Zhenqiu Liu,Yanfeng Jiang,Oumin Shi,Xin Zhang,Kelin Xu,Chen Suo,Qin Wang,Yujing Song,Kangkang Yu,Xianhua Mao,Xuefu Wu,Mingshan Wu,Tingting Shi,Wei Jiang,Lina Mu,Damien C. Tully,Lei Xu,Li Jin,Shusheng Li,Xuejin Tao,Tiejun Zhang,Xingdong Chen +22 more
TL;DR: Age, high-sensitivity C-reactive protein level, lymphocyte count and d-dimer level of COVID-19 patients at admission are informative for the patients’ outcomes.